Does an Eczema Action Plan Improve Atopic Dermatitis? A Single-Site Randomized Controlled Trial
| Autor: | Nicole W Weitz, Julia A. Brown, Suzanne Friedman, Amy Liang, Melissa S. Stockwell |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Adult
Male Parents medicine.medical_specialty Adolescent education Eczema Patient Care Planning Dermatitis Atopic law.invention 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Quality of life (healthcare) Randomized controlled trial law Single site Surveys and Questionnaires 030225 pediatrics Humans Medicine Child business.industry Infant Treatment options Atopic dermatitis Care group medicine.disease Child Preschool Family medicine Action plan Pediatrics Perinatology and Child Health Quality of Life Female Clinical Competence business |
| Zdroj: | Clinical Pediatrics. 57:1624-1629 |
| ISSN: | 1938-2707 0009-9228 |
| DOI: | 10.1177/0009922818795906 |
| Popis: | The multitude of treatment options for atopic dermatitis (AD) makes management frustrating for providers and patients. Eczema action plans (EAPs) have been proposed to improve parental and provider management. We developed a single-site randomized controlled trial to evaluate the impact of an EAP on quality of life (QOL), provider knowledge, and comfort with AD management. Providers were randomized into an EAP-use group and a traditional care group. All patients completed validated AD QOL surveys, and those with AD were verbally administered the survey 1 month later. Providers’ perceptions on managing AD were compared in the EAP and usual use groups. Parents in the EAP group demonstrated a significantly increased understanding of AD treatment, and providers in the EAP group had a significantly increased understanding and management of AD. The EAP is a feasible tool that can be integrated into a busy clinic practice with a positive impact on physicians and patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|